Kovack Advisors’s Celgene Corp CELG Stock Holding History

Kovack Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5	Closed	-$600K	–	562
2018 Q1	$600K	Buy	+5	New	+$480	0.15%	162
2016 Q2	–	Sell	-2	Closed	-$1K	–	304
2016 Q1	$1K	Buy	2 +1	+100%	+$103	﹤0.01%	246
2015 Q4	$1K	Buy	+1	New	+$116	﹤0.01%	234
2015 Q3	–	Sell	-1	Closed	-$1K	–	267
2015 Q2	$1K	Hold	1	–	–	﹤0.01%	212
2015 Q1	$1K	Sell	1 -2	-67%	-$239	﹤0.01%	185
2014 Q4	$2K	Buy	+3	New	+$316	﹤0.01%	162

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Kovack Advisors's CELG Position: Q4 2019 in Review

Kovack Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,030 shares — an estimated $1.69M sold.

Kovack Advisors first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $1.69M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Kovack Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Kovack Advisors sold 17,030 Celgene Corp shares in Q4 2019, an estimated $1.69M.
Kovack Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
Kovack Advisors's Celgene Corp position peaked at $1.69M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Kovack Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.